Comparative Pain Assessment of Intradermal Versus Subdermal Skin Booster Injections Using PDLLA: A Randomized, Double-Blinded Split-Injection Study
- 7 January 2026
- journal article
- research article
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (11) , 4212-4217
Abstract
Background Poly-D,L-lactic acid (PDLLA) skin boosters are widely used for biostimulatory skin rejuvenation, but comparative data on pain perception between injection techniques remain limited. Objective To compare patient-reported pain between intradermal and subdermal PDLLA injections using a randomized, double-blinded, split-injection design. Methods Twenty-one healthy participants (aged 27–64) each received ten facial injections: five intradermal and five subdermal, administered in randomized order using a 32G needle. Pain was assessed using a Visual Analogue Scale (VAS) immediately after each injection. The primary outcome was the difference in mean VAS scores between techniques. Secondary analyses examined the effects of age and gender on pain perception. Results The mean VAS score for intradermal injections was significantly higher than for subdermal injections (6.18 vs. 3.85, p<0.001). No significant gender-based differences were observed. Patients under 40 reported higher intradermal pain than older subjects (p=0.04), but age had no impact on subdermal pain. Conclusion Subdermal PDLLA injections are significantly less painful than intradermal injections, likely due to lower nerve density and reduced dermal resistance. With equivalent efficacy and minimal downtime, subdermal injection may be preferable for patient comfort and compliance. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authorswww.springer.com/00266Keywords
This publication has 12 references indexed in Scilit:
- Preliminary nerve block for intradermal facial skin booster injectionsJournal of Cosmetic Dermatology, 2023
- Observation on cadavers and through ultrasonography using a 2 mm needle length for intradermal injectionsSkin Research and Technology, 2023
- A Novel Technique to Reduce Pain from Intradermal Injection of Botulinum Toxin Type APlastic and Reconstructive Surgery - Global Open, 2021
- Left/Right Pain Asymmetry With Injectable Cosmetic Treatments for the FaceAesthetic Surgery Journal, 2017
- Skin Matters: Identifying Pain Mechanisms and Predicting Treatment OutcomesNeurology Research International, 2013
- Microneedle-Based Intradermal Versus Subcutaneous Administration of Regular Human Insulin or Insulin Lispro: Pharmacokinetics and Postprandial Glycemic Excursions in Patients with Type 1 DiabetesDiabetes Technology & Therapeutics, 2011
- The cutaneous sensory systemNeuroscience & Biobehavioral Reviews, 2010
- Patient Perceptions of Injection Pain and Anxiety: A Comparison of NovoFine 32-Gauge Tip 6mm and Micro Fine Plus 31-Gauge 5mm NeedlesDiabetes Technology & Therapeutics, 2009
- Measurements of human pressure-pain thresholds on fingers and toesPain, 1989
- Pain Mechanisms: A New TheoryScience, 1965